Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ms 27-275
2. Ms 275
3. Ms-27-275
4. Ms-275
5. N-(2-aminophenyl)-4-(n-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide
6. Sndx-275
1. 209783-80-2
2. Ms-275
3. Sndx-275
4. Entinostat (ms-275)
5. Ms 275
6. Ms-27-275
7. Sndx 275
8. Pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate
9. Ms 27-275
10. Ms275
11. Entinostat (ms-275,sndx-275)
12. 1zny4fkk9h
13. Bay 86-5274
14. N-(2-aminophenyl)-4-(n-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide
15. Pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate
16. Chembl27759
17. Pyridin-3-ylmethyl {4-[(2-aminophenyl)carbamoyl]benzyl}carbamate
18. Nsc706995
19. Bay86-5274
20. Nsc-706995
21. Pyridin-3-ylmethyl 4-(2-aminophenylcarbamoyl)benzylcarbamate
22. Ms-275-27
23. Carbamic Acid, N-((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3- Pyridinylmethyl Ester
24. Carbamic Acid, N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-, 3-pyridinylmethyl Ester
25. Pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate.
26. Pyridin-3-ylmethyl N-({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate
27. N-[[4-[(2-aminoanilino)-oxomethyl]phenyl]methyl]carbamic Acid 3-pyridinylmethyl Ester
28. Entinostatum
29. N-(2-aminophenyl)-4-[n-(pyridin-3-ylmethoxycarbonyl)aminomethyl]benzamide
30. Entinostat, Free Base
31. Entinostat [inn]
32. Entinostat [jan]
33. Entinostat [usan:inn]
34. Unii-1zny4fkk9h
35. Entinostat [usan]
36. Ms-275 - Entinostat
37. 3-pyridinylmethyl ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)carbamate
38. Benzamide-type Inhibitor, 3
39. Carbamic Acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3-pyridinylmethyl Ester
40. Entinostat [who-dd]
41. Mls006010183
42. Entinostat (jan/usan/inn)
43. Schembl148309
44. Gtpl7007
45. Dtxsid0041068
46. Bdbm19410
47. Ex-a038
48. Chebi:132082
49. Bcpp000155
50. Hms3426g07
51. Hms3648k12
52. Hms3654o11
53. Hms3744o17
54. Act06782
55. Amy31163
56. Bcp01824
57. Zinc1488870
58. Mfcd08272435
59. Nsc756642
60. S1053
61. Entinostat (ms-275;sndx-275)
62. 3-pyridylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate
63. Akos024262667
64. N-(2-aminophenyl)-4-[n-(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide
65. Ac-8968
66. Bcp9000967
67. Carbamic Acid, 3-pyridinylmethyl Ester
68. Ccg-208680
69. Cs-0511
70. Db11841
71. Entinostat (ms-275, Sndx-275)
72. Nsc 706995
73. Nsc-756642
74. Sb16665
75. Carbamic Acid, [[4-[[(2-aminophenyl)carbaonyl]phenyl]methyl]-, 3-pyridinylmethyl Ester
76. Ncgc00165833-01
77. Ncgc00165833-02
78. Ncgc00165833-03
79. Ncgc00165833-04
80. Ncgc00165833-11
81. Ncgc00165833-13
82. 442532-99-2
83. As-17906
84. Bp-25653
85. Hy-12163
86. Nci60_038022
87. Smr004458705
88. Ms-275, A Hdac1 And Hdac3 Inhibitor
89. Zk 244894
90. E1454
91. Ft-0667871
92. Sw219667-1
93. Ec-000.2117
94. D09338
95. 783m802
96. A815057
97. Ms-275,entinostat, Sndx-275, Ms-27-275
98. Sr-01000946382
99. Q1281020
100. Sr-01000946382-1
101. W-201831
102. Brd-k77908580-001-02-1
103. Brd-k77908580-001-04-7
104. (pyridin-3-yl)methyl 4-(2-aminophenylcarbamoyl)benzylcarbamate
105. Pyridin-3-ylmethyl4-((2-aminophenyl)carbamoyl)benzylcarbamate
106. N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-3-pyridinylmethyl Ester, Carbamic Acid
107. N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamic Acid 3-pyridinylmethyl Ester
108. Pyridin-3-ylmethyl ((4-((2-aminophenyl)carbamoyl)phenyl)methyl)carbamate
109. Sndx 275;3-pyridylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate
| Molecular Weight | 376.4 g/mol |
|---|---|
| Molecular Formula | C21H20N4O3 |
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 376.15354051 g/mol |
| Monoisotopic Mass | 376.15354051 g/mol |
| Topological Polar Surface Area | 106 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 508 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Histone Deacetylase Inhibitors
Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01X - Other antineoplastic agents
L01XH - Histone deacetylase (hdac) inhibitors
L01XH05 - Entinostat
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Entinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Entinostat, including repackagers and relabelers. The FDA regulates Entinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Entinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Entinostat supplier is an individual or a company that provides Entinostat active pharmaceutical ingredient (API) or Entinostat finished formulations upon request. The Entinostat suppliers may include Entinostat API manufacturers, exporters, distributors and traders.
click here to find a list of Entinostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Entinostat DMF (Drug Master File) is a document detailing the whole manufacturing process of Entinostat active pharmaceutical ingredient (API) in detail. Different forms of Entinostat DMFs exist exist since differing nations have different regulations, such as Entinostat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Entinostat DMF submitted to regulatory agencies in the US is known as a USDMF. Entinostat USDMF includes data on Entinostat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Entinostat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Entinostat suppliers with USDMF on PharmaCompass.
Entinostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Entinostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Entinostat GMP manufacturer or Entinostat GMP API supplier for your needs.
A Entinostat CoA (Certificate of Analysis) is a formal document that attests to Entinostat's compliance with Entinostat specifications and serves as a tool for batch-level quality control.
Entinostat CoA mostly includes findings from lab analyses of a specific batch. For each Entinostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Entinostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Entinostat EP), Entinostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Entinostat USP).
LOOKING FOR A SUPPLIER?
